AIM: Implementation of targeted e-mental health interventions offers a promising solution to reducing the burden of disease associated with youth depression. A single-group pilot study was conducted to evaluate the acceptability, feasibility, usability and safety of a novel, moderated online social therapy intervention (entitled Rebound) for depression relapse prevention in young people. METHODS: Participants were 42 young people (15-25 years) (50% men; mean age = 18.5 years) in partial or full remission. Participants had access to the Rebound platform for at least 12 weeks, including the social networking, peer and clinical moderator and therapy components. RESULTS: Follow-up data were available for 39 (92.9%) participants. There was high system usage, with 3034 user logins (mean = 72.2 per user) and 2146 posts (mean = 51.1). Almost 70% of users had ≥10 logins over the 12 weeks, with 78.5% logging in over at least 2 months of the pilot. A total of 32 (84%) participants rated the intervention as helpful. There was significant improvement between the number of participants in full remission at baseline (n = 5; none of whom relapsed) relative to n = 19 at 12-week follow-up (P < 0.001). Six (14.3%) participants relapsed to full threshold symptoms at 12 weeks. There was a significant improvement to interviewer-rated depression scores (Montgomery-Asberg Depression Rating Scale (MADRS); P = 0.014, d = 0.45) and a trend for improved strength use (P = 0.088, d = 0.29). The single-group design and 12-week treatment phase preclude a full understanding of the clinical benefits of the Rebound intervention. CONCLUSIONS: The Rebound intervention was shown to be acceptable, feasible, highly usable and safe in young people with major depression.
AIM: Implementation of targeted e-mental health interventions offers a promising solution to reducing the burden of disease associated with youth depression. A single-group pilot study was conducted to evaluate the acceptability, feasibility, usability and safety of a novel, moderated online social therapy intervention (entitled Rebound) for depression relapse prevention in young people. METHODS:Participants were 42 young people (15-25 years) (50% men; mean age = 18.5 years) in partial or full remission. Participants had access to the Rebound platform for at least 12 weeks, including the social networking, peer and clinical moderator and therapy components. RESULTS: Follow-up data were available for 39 (92.9%) participants. There was high system usage, with 3034 user logins (mean = 72.2 per user) and 2146 posts (mean = 51.1). Almost 70% of users had ≥10 logins over the 12 weeks, with 78.5% logging in over at least 2 months of the pilot. A total of 32 (84%) participants rated the intervention as helpful. There was significant improvement between the number of participants in full remission at baseline (n = 5; none of whom relapsed) relative to n = 19 at 12-week follow-up (P < 0.001). Six (14.3%) participants relapsed to full threshold symptoms at 12 weeks. There was a significant improvement to interviewer-rated depression scores (Montgomery-Asberg Depression Rating Scale (MADRS); P = 0.014, d = 0.45) and a trend for improved strength use (P = 0.088, d = 0.29). The single-group design and 12-week treatment phase preclude a full understanding of the clinical benefits of the Rebound intervention. CONCLUSIONS: The Rebound intervention was shown to be acceptable, feasible, highly usable and safe in young people with major depression.
Authors: Joseph Firth; John Torous; Brendon Stubbs; Josh A Firth; Genevieve Z Steiner; Lee Smith; Mario Alvarez-Jimenez; John Gleeson; Davy Vancampfort; Christopher J Armitage; Jerome Sarris Journal: World Psychiatry Date: 2019-06 Impact factor: 49.548
Authors: Kathryn N Tomasino; Emily G Lattie; Joyce Ho; Hannah L Palac; Susan M Kaiser; David C Mohr Journal: Am J Geriatr Psychiatry Date: 2017-05-03 Impact factor: 4.105
Authors: Patrick D McGorry; Cristina Mei; Andrew Chanen; Craig Hodges; Mario Alvarez-Jimenez; Eóin Killackey Journal: World Psychiatry Date: 2022-02 Impact factor: 49.548
Authors: Gigi Toh; Eiluned Pearce; John Vines; Sarah Ikhtabi; Mary Birken; Alexandra Pitman; Sonia Johnson Journal: BMC Psychiatry Date: 2022-05-12 Impact factor: 4.144
Authors: Lori Wozney; Anna Huguet; Kathryn Bennett; Ashley D Radomski; Lisa Hartling; Michele Dyson; Amanda S Newton; Patrick J McGrath Journal: J Med Internet Res Date: 2017-08-09 Impact factor: 5.428
Authors: Simon D'Alfonso; Olga Santesteban-Echarri; Simon Rice; Greg Wadley; Reeva Lederman; Christopher Miles; John Gleeson; Mario Alvarez-Jimenez Journal: Front Psychol Date: 2017-06-02
Authors: Simon Rice; John Gleeson; Steven Leicester; Sarah Bendall; Simon D'Alfonso; Tamsyn Gilbertson; Eoin Killackey; Alexandra Parker; Reeva Lederman; Greg Wadley; Olga Santesteban-Echarri; Ingrid Pryor; Daveena Mawren; Aswin Ratheesh; Mario Alvarez-Jimenez Journal: JMIR Res Protoc Date: 2018-02-22